Kommentar
A one-way street recognition approach to mediate allogeneic immune cell therapies
Cell Stem Cell · 2024
DOI: 10.1016/j.stem.2024.07.005 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Stem Cell, 2024. Verfasst von Fuguo Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Killer Cells, NaturalHumansTransplantation, HomologousCD58 AntigensT-LymphocytesCell- and Tissue-Based Therapy
Substanzen
CD58 Antigens
Autor:innen und Institutionen
- Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
- Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: rizwan_romee@dfci.harvard.edu.
Zitieren
APA
Liu, F., & Romee, R. (2024). A one-way street recognition approach to mediate allogeneic immune cell therapies. Cell Stem Cell. https://doi.org/10.1016/j.stem.2024.07.005
Vancouver
Liu F, Romee R. A one-way street recognition approach to mediate allogeneic immune cell therapies. Cell Stem Cell. 2024. doi:10.1016/j.stem.2024.07.005
BibTeX
@article{Liu2024,
author = {Liu, Fuguo and Romee, Rizwan},
title = {A one-way street recognition approach to mediate allogeneic immune cell therapies},
journal = {Cell Stem Cell},
year = {2024},
doi = {10.1016/j.stem.2024.07.005}
}
EUVIMED